{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:01Z","timestamp":1790948341667,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10792-020-01539-6","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T14:05:21Z","timestamp":1599746721000},"page":"3599-3612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ocular surgery after herpes simplex and herpes zoster keratitis"],"prefix":"10.1007","volume":"40","author":[{"given":"Piotr","family":"Kanclerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8082-1751","authenticated-orcid":false,"given":"Jorge L.","family":"Alio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"issue":"Suppl 1","key":"1539_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","volume":"186","author":"JS Smith","year":"2002","unstructured":"Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186(Suppl 1):S3\u2013S28","journal-title":"J Infect Dis"},{"key":"1539_CR2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/ceo.12991","volume":"45","author":"M Tsatsos","year":"2017","unstructured":"Tsatsos M, MacGregor C, Athanasiadis I et al (2017) Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents\u2014comment. Clin Exp Ophthalmol 45:932","journal-title":"Clin Exp Ophthalmol"},{"key":"1539_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0039-6257(76)90090-4","volume":"21","author":"CR Dawson","year":"1976","unstructured":"Dawson CR, Togni B (1976) Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 21:121\u2013135","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"1539_CR4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","volume":"194","author":"AL Cunningham","year":"2006","unstructured":"Cunningham AL, Diefenbach RJ, Miranda-Saksena M et al (2006) The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 194(Suppl 1):S11\u2013S18","journal-title":"J Infect Dis"},{"key":"1539_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000307814","volume":"173","author":"V Ribari\u0107","year":"1976","unstructured":"Ribari\u0107 V (1976) The incidence of herpetic keratitis among population. Ophthalmologica 173:19\u201322","journal-title":"Ophthalmologica"},{"key":"1539_CR6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","volume":"107","author":"TJ Liesegang","year":"1989","unstructured":"Liesegang TJ (1989) Epidemiology of ocular herpes simplex. Arch Ophthalmol 107:1155","journal-title":"Arch Ophthalmol"},{"key":"1539_CR7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ophtha.2004.11.052","volume":"112","author":"M Labetoulle","year":"2005","unstructured":"Labetoulle M, Auquier P, Conrad H et al (2005) Incidence of herpes simplex virus keratitis in France. Ophthalmology 112:888\u2013895","journal-title":"Ophthalmology"},{"key":"1539_CR8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9394(81)90285-3","volume":"91","author":"JJ Shuster","year":"1981","unstructured":"Shuster JJ, Kaufman HE, Nesburn AB (1981) Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol 91:328\u2013331","journal-title":"Am J Ophthalmol"},{"key":"1539_CR9","first-page":"0707","volume":"2008","author":"NH Barker","year":"2008","unstructured":"Barker NH (2008) Ocular herpes simplex. BMJ Clin Evid 2008:0707","journal-title":"BMJ Clin Evid"},{"key":"1539_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.survophthal.2008.12.004","volume":"54","author":"JE Knickelbein","year":"2009","unstructured":"Knickelbein JE, Hendricks RL, Charukamnoetkanok P (2009) Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol 54:226\u2013234","journal-title":"Surv Ophthalmol"},{"key":"1539_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","volume":"11","author":"TN Azher","year":"2017","unstructured":"Azher TN, Yin X, Tajfirouz D, Huang AJH, Stuart PM (2017) Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol 11:185\u2013191","journal-title":"Clin Ophthalmol"},{"key":"1539_CR12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICL.0b013e31829a3b47","volume":"39","author":"ARP Edell","year":"2013","unstructured":"Edell ARP, Cohen EJ (2013) Herpes simplex and herpes zoster eye disease. Eye Contact Lens 39:311\u2013314","journal-title":"Eye Contact Lens"},{"key":"1539_CR13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","volume":"115","author":"TJ Liesegang","year":"2008","unstructured":"Liesegang TJ (2008) Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 115:S3\u2013S12","journal-title":"Ophthalmology"},{"key":"1539_CR14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/ICO.0b013e318033a708","volume":"26","author":"IS Barequet","year":"2007","unstructured":"Barequet IS, Wasserzug Y (2007) Herpes simplex keratitis after cataract surgery. Cornea 26:615\u2013617","journal-title":"Cornea"},{"key":"1539_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/ICO.0b013e318182262c","volume":"28","author":"NN Patel","year":"2009","unstructured":"Patel NN, Teng CC, Sperber LTD, Dodick JM (2009) New-onset herpes simplex virus keratitis after cataract surgery. Cornea 28:108\u2013110","journal-title":"Cornea"},{"key":"1539_CR16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3928\/1081-597X-20050701-17","volume":"21","author":"J Levy","year":"2005","unstructured":"Levy J, Lapid-Gortzak R, Klemperer I, Lifshitz T (2005) Herpes simplex virus keratitis after laser in situ keratomileusis. J Refract Surg 21:400\u2013402","journal-title":"J Refract Surg"},{"key":"1539_CR17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/ICO.0000000000001592","volume":"37","author":"YK Cho","year":"2018","unstructured":"Cho YK, Kwon JW, Konda S, Ambati BK (2018) Epithelial keratitis after cataract surgery. Cornea 37:755\u2013759","journal-title":"Cornea"},{"key":"1539_CR18","doi-asserted-by":"crossref","first-page":"e16591","DOI":"10.1097\/MD.0000000000016591","volume":"98","author":"M Zou","year":"2019","unstructured":"Zou M, Zhang Y, Huang X et al (2019) Epithelial keratitis mimicking herpes simplex keratitis in a patient after cataract surgery: a case report. Medicine 98:e16591","journal-title":"Medicine"},{"key":"1539_CR19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2007.10.005","volume":"145","author":"S Ghosh","year":"2008","unstructured":"Ghosh S, Jhanji V, Lamoureux E et al (2008) Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am J Ophthalmol 145:198\u2013202","journal-title":"Am J Ophthalmol"},{"key":"1539_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.86.6.646","volume":"86","author":"M Halberstadt","year":"2002","unstructured":"Halberstadt M, Machens M, Gahlenbek K-A et al (2002) The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin. Br J Ophthalmol 86:646\u2013652","journal-title":"Br J Ophthalmol"},{"key":"1539_CR21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/eye.2010.237","volume":"25","author":"JFB Goodfellow","year":"2011","unstructured":"Goodfellow JFB, Nabili S, Jones MNA et al (2011) Antiviral treatment following penetrating keratoplasty for herpetic keratitis. Eye 25:470\u2013474","journal-title":"Eye"},{"issue":"Pt 4","key":"1539_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/eye.1988.73","volume":"2","author":"LA Ficker","year":"1988","unstructured":"Ficker LA, Kirkness CM, Rice NS, Steele AD (1988) Longterm prognosis for corneal grafting in herpes simplex keratitis. Eye 2(Pt 4):400\u2013408","journal-title":"Eye"},{"key":"1539_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003226-199405000-00007","volume":"13","author":"NP Barney","year":"1994","unstructured":"Barney NP, Foster CS (1994) A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 13:232\u2013236","journal-title":"Cornea"},{"key":"1539_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.117.4.445","volume":"117","author":"FP Tambasco","year":"1999","unstructured":"Tambasco FP, Cohen EJ, Nguyen LH et al (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117:445","journal-title":"Arch Ophthalmol"},{"key":"1539_CR25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bjo.2009.169300","volume":"94","author":"MA Awan","year":"2010","unstructured":"Awan MA, Roberts F, Hegarty B, Ramaesh K (2010) The outcome of deep anterior lamellar keratoplasty in herpes simplex virus-related corneal scarring, complications and graft survival. Br J Ophthalmol 94:1300\u20131303","journal-title":"Br J Ophthalmol"},{"key":"1539_CR26","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/bjophthalmol-2015-307427","volume":"100","author":"A Ogawa","year":"2016","unstructured":"Ogawa A, Yamaguchi T, Mitamura H et al (2016) Aetiology-specific comparison of long-term outcome of deep anterior lamellar keratoplasty for corneal diseases. Br J Ophthalmol 100:1176\u20131182","journal-title":"Br J Ophthalmol"},{"key":"1539_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2017.09.017","volume":"184","author":"E Shimizu","year":"2017","unstructured":"Shimizu E, Yamaguchi T, Tomida D et al (2017) Corneal higher-order aberrations and visual improvement following corneal transplantation in treating herpes simplex keratitis. Am J Ophthalmol 184:1\u201310","journal-title":"Am J Ophthalmol"},{"key":"1539_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajo.2011.07.020","volume":"153","author":"S-Q Wu","year":"2012","unstructured":"Wu S-Q, Zhou P, Zhang B et al (2012) Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis. Am J Ophthalmol 153:291\u2013299.e2","journal-title":"Am J Ophthalmol"},{"key":"1539_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0000000000000742","volume":"35","author":"Y Ren","year":"2016","unstructured":"Ren Y, Wang H, Zheng Q et al (2016) Long-term outcomes of deep anterior lamellar keratoplasty treating posterior stroma-implicated herpetic corneal opacities. Cornea 35:299\u2013304","journal-title":"Cornea"},{"key":"1539_CR30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bjophthalmol-2012-301947","volume":"96","author":"DAM Lyall","year":"2012","unstructured":"Lyall DAM, Tarafdar S, Gilhooly MJ et al (2012) Long term visual outcomes, graft survival and complications of deep anterior lamellar keratoplasty in patients with herpes simplex related corneal scarring. Br J Ophthalmol 96:1200\u20131203","journal-title":"Br J Ophthalmol"},{"key":"1539_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5935\/0004-2749.20170011","volume":"80","author":"Y Altay","year":"2017","unstructured":"Altay Y, Tamer S, Kaya AS et al (2017) The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis. Arq Bras Oftalmol 80:41\u201345","journal-title":"Arq Bras Oftalmol"},{"key":"1539_CR32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcrs.2019.01.003","volume":"45","author":"LM Lu","year":"2019","unstructured":"Lu LM, McGhee CNJ, Sims JL, Niederer RL (2019) High rate of recurrence of herpes zoster-related ocular disease after phacoemulsification cataract surgery. J Cataract Refract Surg 45:810\u2013815","journal-title":"J Cataract Refract Surg"},{"key":"1539_CR33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jcrs.2014.07.036","volume":"41","author":"Y He","year":"2015","unstructured":"He Y, de Melo Franco R, Kron-Gray MM et al (2015) Outcomes of cataract surgery in eyes with previous herpes zoster ophthalmicus. J Cataract Refract Surg 41:771\u2013777","journal-title":"J Cataract Refract Surg"},{"key":"1539_CR34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00417-018-04210-0","volume":"257","author":"A Grzybowski","year":"2019","unstructured":"Grzybowski A, Kanclerz P (2019) Do we need day-1 postoperative follow-up after cataract surgery? Graefes Arch Clin Exp Ophthalmol 257:855\u2013861","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3928\/1081-597X-20060401-19","volume":"22","author":"MV de Rojas Silva","year":"2006","unstructured":"de Rojas Silva MV, D\u00edez-Feij\u00f3o E, Javaloy J, S\u00e1nchez-Salorio M (2006) Prophylactic perioperative antiviral therapy for LASIK in patients with inactive herpetic keratitis. J Refract Surg 22:404\u2013406","journal-title":"J Refract Surg"},{"key":"1539_CR36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(01)01092-3","volume":"132","author":"EF Jarade","year":"2001","unstructured":"Jarade EF, Tabbara KF (2001) Laser in situ keratomileusis in eyes with inactive herpetic keratitis. Am J Ophthalmol 132:779\u2013780","journal-title":"Am J Ophthalmol"},{"key":"1539_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-25389-9_3","volume-title":"Current concepts in ophthalmology","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Kanclerz P (2020) Recent developments in cataract surgery. In: Grzybowski A (ed) Current concepts in ophthalmology. Springer, Cham, pp 55\u201397"},{"key":"1539_CR38","unstructured":"(2014) Herpes simplex virus keratitis: a treatment guideline\u20142014. In: American Academy of Ophthalmology. https:\/\/www.aao.org\/clinical-statement\/herpes-simplex-virus-keratitis-treatment-guideline. Accessed 1 Sept 2019"},{"key":"1539_CR39","first-page":"CD007824","volume":"11","author":"UK Bhatt","year":"2016","unstructured":"Bhatt UK, Abdul Karim MN, Prydal JI et al (2016) Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts. Cochrane Database Syst Rev 11:CD007824","journal-title":"Cochrane Database Syst Rev"},{"key":"1539_CR40","unstructured":"Scottish Intercollegiate Guidelines Network. Annex B: key to evidence statements and grades of recommendations. In: SIGN 50: a guideline developer\u2019s handbook. 2008 edition, revised 2011. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network. https:\/\/www.sign.ac.uk\/assets\/sign50_2011.pdf. Accessed 15 June 2020"},{"key":"1539_CR41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"1539_CR42","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0161-6420(03)00798-X","volume":"110","author":"J van Rooij","year":"2003","unstructured":"van Rooij J, Rijneveld WJ, Remeijer L et al (2003) Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 110:1916\u20131919 discussion 1919","journal-title":"Ophthalmology"},{"key":"1539_CR43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e318198399a","volume":"28","author":"AFG Jansen","year":"2009","unstructured":"Jansen AFG, Rijneveld WJ, Remeijer L et al (2009) Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. Cornea 28:843\u2013845","journal-title":"Cornea"},{"key":"1539_CR44","doi-asserted-by":"crossref","first-page":"e4892","DOI":"10.1097\/MD.0000000000004892","volume":"95","author":"X Liu","year":"2016","unstructured":"Liu X, Zhou Q, Huang X et al (2016) Clinical evaluation of deep anterior lamellar keratoplasty using glycerol-cryopreserved corneal tissues for refractory herpetic stromal keratitis: an observational study. Medicine 95:e4892","journal-title":"Medicine"},{"key":"1539_CR45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/ICO.0b013e3181930a7e","volume":"28","author":"A Leccisotti","year":"2009","unstructured":"Leccisotti A (2009) Air-assisted manual deep anterior lamellar keratoplasty for treatment of herpetic corneal scars. Cornea 28:728\u2013731","journal-title":"Cornea"},{"key":"1539_CR46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","volume":"144","author":"NX Nguyen","year":"2007","unstructured":"Nguyen NX, Seitz B, Martus P et al (2007) Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol 144:318\u2013319","journal-title":"Am J Ophthalmol"},{"key":"1539_CR47","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.transproceed.2007.04.009","volume":"39","author":"G Hassan","year":"2007","unstructured":"Hassan G, Khalaf H, Mourad W (2007) Dermatologic complications after liver transplantation: a single-center experience. Transplant Proc 39:1190\u20131194","journal-title":"Transplant Proc"},{"key":"1539_CR48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181a317d3","volume":"29","author":"V Sarnicola","year":"2010","unstructured":"Sarnicola V, Toro P (2010) Deep anterior lamellar keratoplasty in herpes simplex corneal opacities. Cornea 29:60\u201364","journal-title":"Cornea"},{"key":"1539_CR49","doi-asserted-by":"crossref","first-page":"251584142091301","DOI":"10.1177\/2515841420913014","volume":"12","author":"S Feizi","year":"2020","unstructured":"Feizi S, Azari AA (2020) Approaches toward enhancing survival probability following deep anterior lamellar keratoplasty. Ther Adv Ophthalmol 12:2515841420913014","journal-title":"Ther Adv Ophthalmol"},{"key":"1539_CR50","first-page":"1710","volume":"103","author":"TS Tanaka","year":"2019","unstructured":"Tanaka TS, Hood CT, Kriegel MF et al (2019) Long-term outcomes of penetrating keratoplasty for corneal complications of herpes zoster ophthalmicus. Br J Ophthalmol 103:1710\u20131715","journal-title":"Br J Ophthalmol"},{"key":"1539_CR51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjophthalmol-2013-304199","volume":"98","author":"J Li","year":"2014","unstructured":"Li J, Ma H, Zhao Z et al (2014) Deep anterior lamellar keratoplasty using precut anterior lamellar cap for herpes simplex keratitis: a long-term follow-up study. Br J Ophthalmol 98:448\u2013453","journal-title":"Br J Ophthalmol"},{"key":"1539_CR52","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00417-012-1947-2","volume":"250","author":"J Wang","year":"2012","unstructured":"Wang J, Zhao G, Xie L et al (2012) Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol 250:1187\u20131194","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2008.138065","volume":"92","author":"D Goldblum","year":"2008","unstructured":"Goldblum D, Bachmann C, Tappeiner C et al (2008) Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis. Br J Ophthalmol 92:1201\u20131205","journal-title":"Br J Ophthalmol"},{"key":"1539_CR54","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/ICO.0b013e3180e79b77","volume":"26","author":"DD Garcia","year":"2007","unstructured":"Garcia DD, Farjo Q, Musch DC, Sugar A (2007) Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 26:930\u2013934","journal-title":"Cornea"},{"key":"1539_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1076\/ocii.7.1.51.8113","volume":"7","author":"YA Akova","year":"1999","unstructured":"Akova YA, Onat M, Duman S (1999) Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex keratitis. Ocul Immunol Inflamm 7:51\u201360","journal-title":"Ocul Immunol Inflamm"},{"key":"1539_CR56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1755-3768.1994.tb02796.x","volume":"72","author":"P Fagerholm","year":"1994","unstructured":"Fagerholm P, Ohman L, Orndahl M (1994) Phototherapeutic keratectomy in herpes simplex keratitis. Clinical results in 20 patients. Acta Ophthalmol 72:457\u2013460","journal-title":"Acta Ophthalmol"},{"key":"1539_CR57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.68.3.192","volume":"68","author":"SO Hung","year":"1984","unstructured":"Hung SO, Patterson A, Rees PJ (1984) Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol 68:192\u2013195","journal-title":"Br J Ophthalmol"},{"key":"1539_CR58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/infdis\/141.5.563","volume":"141","author":"E De Clercq","year":"1980","unstructured":"De Clercq E, Descamps J, Verhelst G et al (1980) Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis 141:563\u2013574","journal-title":"J Infect Dis"},{"key":"1539_CR59","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/AAC.15.5.642","volume":"15","author":"CS Crumpacker","year":"1979","unstructured":"Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ (1979) Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother 15:642\u2013645","journal-title":"Antimicrob Agents Chemother"},{"key":"1539_CR60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2008.03.015","volume":"359","author":"S Katragadda","year":"2008","unstructured":"Katragadda S, Gunda S, Hariharan S, Mitra AK (2008) Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int J Pharm 359:15\u201324","journal-title":"Int J Pharm"},{"key":"1539_CR61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/bjo.70.2.138","volume":"70","author":"J Schulman","year":"1986","unstructured":"Schulman J, Peyman GA, Fiscella R et al (1986) Intraocular acyclovir levels after subconjunctival and topical administration. Br J Ophthalmol 70:138\u2013140","journal-title":"Br J Ophthalmol"},{"key":"1539_CR62","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1001\/archopht.1982.01030040944016","volume":"100","author":"RH Poirier","year":"1982","unstructured":"Poirier RH, Kingham JD, de Miranda P, Annel M (1982) Intraocular antiviral penetration. Arch Ophthalmol 100:1964\u20131967","journal-title":"Arch Ophthalmol"},{"key":"1539_CR63","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archopht.1983.01040020148031","volume":"101","author":"DT Weaver","year":"1983","unstructured":"Weaver DT, Isenberg SJ (1983) Intraocular antiviral penetration. Arch Ophthalmol 101:1146","journal-title":"Arch Ophthalmol"},{"key":"1539_CR64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.31.3.361","volume":"31","author":"D Gold","year":"1987","unstructured":"Gold D, Corey L (1987) Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother 31:361\u2013367","journal-title":"Antimicrob Agents Chemother"},{"key":"1539_CR65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","volume":"339","author":"KR Wilhelmus","year":"1998","unstructured":"Wilhelmus KR, Beck RW, Moke PS et al (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 339:300\u2013306","journal-title":"N Engl J Med"},{"key":"1539_CR66","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcrs.2016.06.006","volume":"42","author":"RS Hoffman","year":"2016","unstructured":"Hoffman RS, Braga-Mele R, Donaldson K et al (2016) Cataract surgery and nonsteroidal antiinflammatory drugs. J Cataract Refract Surg 42:1368\u20131379","journal-title":"J Cataract Refract Surg"},{"key":"1539_CR67","doi-asserted-by":"crossref","first-page":"22766","DOI":"10.3402\/jom.v5i0.22766","volume":"5","author":"B Grinde","year":"2013","unstructured":"Grinde B (2013) Herpesviruses: latency and reactivation\u2014viral strategies and host response. J Oral Microbiol 5:22766","journal-title":"J Oral Microbiol"},{"key":"1539_CR68","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1101\/gad.190157.112","volume":"26","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Wilson AC, Chao MV, Mohr I (2012) Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. Genes Dev 26:1527\u20131532","journal-title":"Genes Dev"},{"key":"1539_CR69","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1073\/pnas.95.12.7231","volume":"95","author":"DA Padgett","year":"1998","unstructured":"Padgett DA, Sheridan JF, Dorne J et al (1998) Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 95:7231\u20137235","journal-title":"Proc Natl Acad Sci USA"},{"key":"1539_CR70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","volume":"32","author":"AM Rowe","year":"2013","unstructured":"Rowe AM, St Leger AJ, Jeon S et al (2013) Herpes keratitis. Prog Retin Eye Res 32:88\u2013101","journal-title":"Prog Retin Eye Res"},{"key":"1539_CR71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00003226-200103000-00001","volume":"20","author":"Herpetic Eye Disease Study Group","year":"2001","unstructured":"Herpetic Eye Disease Study Group (2001) Predictors of recurrent herpes simplex virus keratitis. Cornea 20:123\u2013128","journal-title":"Cornea"},{"key":"1539_CR72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/fmb.11.73","volume":"6","author":"LJ Al-Dujaili","year":"2011","unstructured":"Al-Dujaili LJ, Clerkin PP, Clement C et al (2011) Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol 6:877\u2013907","journal-title":"Future Microbiol"},{"key":"1539_CR73","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archopht.1991.01080120065027","volume":"109","author":"F Malecaze","year":"1991","unstructured":"Malecaze F, Chollet P, Cavrois E et al (1991) Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol 109:1681\u20131683","journal-title":"Arch Ophthalmol"},{"key":"1539_CR74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/13550289709031190","volume":"3","author":"JD Kriesel","year":"1997","unstructured":"Kriesel JD, Ricigliano J, Spruance S et al (1997) Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol 3:441\u2013448","journal-title":"J Neurovirol"},{"key":"1539_CR75","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/170.4.1046","volume":"170","author":"JD Kriesel","year":"1994","unstructured":"Kriesel JD, Araneo B, Petajan JP et al (1994) Herpes labialis associated with recombinant human ciliary neurotrophic factor. J Infect Dis 170:1046","journal-title":"J Infect Dis"},{"key":"1539_CR76","first-page":"925","volume":"31","author":"CF Beyer","year":"1990","unstructured":"Beyer CF, Hill JM, Reidy JJ, Beuerman RW (1990) Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest Ophthalmol Vis Sci 31:925\u2013932","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR77","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1167\/iovs.16-20557","volume":"57","author":"P Rosenthal","year":"2016","unstructured":"Rosenthal P, Borsook D, Moulton EA (2016) Oculofacial pain: corneal nerve damage leading to pain beyond the eye. Invest Ophthalmol Vis Sci 57:5285\u20135287","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120922448","author":"P Kanclerz","year":"2020","unstructured":"Kanclerz P, Alio JL (2020) The benefits and drawbacks of femtosecond laser-assisted cataract surgery. Eur J Ophthalmol (in press). https:\/\/doi.org\/10.1177\/1120672120922448","journal-title":"Eur J Ophthalmol"},{"key":"1539_CR79","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1128\/jvi.71.7.5268-5276.1997","volume":"71","author":"R Tal-Singer","year":"1997","unstructured":"Tal-Singer R, Lasner TM, Podrzucki W et al (1997) Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 71:5268\u20135276","journal-title":"J Virol"},{"key":"1539_CR80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JVI.72.2.1252-1261.1998","volume":"72","author":"R Tal-Singer","year":"1998","unstructured":"Tal-Singer R, Podrzucki W, Lasner TM et al (1998) Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interferon regulatory factor-1. J Virol 72:1252\u20131261","journal-title":"J Virol"},{"key":"1539_CR81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08820530802111085","volume":"23","author":"HS Toma","year":"2008","unstructured":"Toma HS, Murina AT, Areaux RG Jr et al (2008) Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 23:249\u2013273","journal-title":"Semin Ophthalmol"},{"key":"1539_CR82","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9394(00)00811-4","volume":"131","author":"DK Dhaliwal","year":"2001","unstructured":"Dhaliwal DK, Romanowski EG, Yates KA et al (2001) Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am J Ophthalmol 131:506\u2013507","journal-title":"Am J Ophthalmol"},{"key":"1539_CR83","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0002-9394(99)80189-5","volume":"125","author":"DK Dhaliwal","year":"1998","unstructured":"Dhaliwal DK, Barnhorst DA Jr, Romanowski E et al (1998) Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model. Am J Ophthalmol 125:488\u2013492","journal-title":"Am J Ophthalmol"},{"key":"1539_CR84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(14)77411-2","volume":"114","author":"JS Pepose","year":"1992","unstructured":"Pepose JS, Laycock KA, Miller JK et al (1992) Reactivation of latent herpes simplex virus by excimer laser photokeratectomy. Am J Ophthalmol 114:45\u201350","journal-title":"Am J Ophthalmol"},{"key":"1539_CR85","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1128\/jvi.61.7.2311-2315.1987","volume":"61","author":"CL Wilcox","year":"1987","unstructured":"Wilcox CL, Johnson EM Jr (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol 61:2311\u20132315","journal-title":"J Virol"},{"key":"1539_CR86","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/jvi.66.4.2150-2156.1992","volume":"66","author":"NM Sawtell","year":"1992","unstructured":"Sawtell NM, Thompson RL (1992) Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 66:2150\u20132156","journal-title":"J Virol"},{"key":"1539_CR87","first-page":"2741","volume":"32","author":"KA Laycock","year":"1991","unstructured":"Laycock KA, Lee SF, Brady RH, Pepose JS (1991) Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci 32:2741\u20132746","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR88","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.infrared.2010.06.003","volume":"53","author":"U Brunsmann","year":"2010","unstructured":"Brunsmann U, Sauer U, Arba-Mosquera S et al (2010) Evaluation of thermal load during laser corneal refractive surgery using infrared thermography. Infrared Phys Technol 53:342\u2013347","journal-title":"Infrared Phys Technol"},{"key":"1539_CR89","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.optom.2018.05.002","volume":"12","author":"D De Ortueta","year":"2019","unstructured":"De Ortueta D, Arba-Mosquera S, Magnago T (2019) High-speed recording of thermal load during laser trans-epithelial corneal refractive surgery using a 750\u00a0Hz ablation system. J Optom 12:84\u201391","journal-title":"J Optom"},{"key":"1539_CR90","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jcrs.2010.02.013","volume":"36","author":"KS Bower","year":"2010","unstructured":"Bower KS, Edwards JD, Ryan DS et al (2010) Scattered ultraviolet emissions during refractive surgery using a high-frequency, wavefront-optimized excimer laser platform. J Cataract Refract Surg 36:1344\u20131348","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"1539_CR91","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/jcm8050716","volume":"8","author":"A Grzybowski","year":"2019","unstructured":"Grzybowski A, Kanclerz P, Huerva V, Ascaso FJ, Tuuminen R (2019) Diabetes and Phacoemulsification Cataract Surgery: Difficulties, Risks and Potential Complications. J Clin Med. 8(5):716","journal-title":"J Clin Med."},{"issue":"8","key":"1539_CR92","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00417-017-3698-6","volume":"255","author":"A Grzybowski","year":"2017","unstructured":"Grzybowski A, Kanclerz P, Pleyer U (2017) Challenges with cataract surgery in pars planitis patients. Graefes Arch Clin Exp Ophthalmol. 255(8):1483\u20131484","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"1539_CR93","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-2004-812851","volume":"221","author":"MM Moschos","year":"2004","unstructured":"Moschos MM, Bui M-A, Guex-Crosier Y (2004) Phacoemulsification with intraocular lens implantation in patients with uveitis. Klin Monbl Augenheilkd 221:324\u2013327","journal-title":"Klin Monbl Augenheilkd"},{"key":"1539_CR94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00055735-200102000-00011","volume":"12","author":"JN Simone","year":"2001","unstructured":"Simone JN, Whitacre MM (2001) Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol 12:63\u201367","journal-title":"Curr Opin Ophthalmol"},{"key":"1539_CR95","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.2174\/1381612825666190206104524","volume":"24","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Kanclerz P (2018) The role of steroids and NSAIDs in prevention and treatment of postsurgical cystoid macular edema. Curr Pharm Des 24:4896\u20134902","journal-title":"Curr Pharm Des"},{"key":"1539_CR96","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0002-9378(85)90144-9","volume":"151","author":"DA Baker","year":"1985","unstructured":"Baker DA, Thomas J (1985) The effect of prostaglandin E2 on the initial immune response to herpes simplex virus infection. Am J Obstet Gynecol 151:586\u2013590","journal-title":"Am J Obstet Gynecol"},{"key":"1539_CR97","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/archopht.1989.01070020742039","volume":"107","author":"MD Trousdale","year":"1989","unstructured":"Trousdale MD, Barlow WE, McGuigan LJ (1989) Assessment of diclofenac on herpes keratitis in rabbit eyes. Arch Ophthalmol 107:1664\u20131666","journal-title":"Arch Ophthalmol"},{"key":"1539_CR98","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0002-9394(99)00089-6","volume":"127","author":"HE Kaufman","year":"1999","unstructured":"Kaufman HE, Varnell ED, Thompson HW (1999) Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol 127:531\u2013536","journal-title":"Am J Ophthalmol"},{"key":"1539_CR99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jop.2005.21.114","volume":"21","author":"BM Gebhardt","year":"2005","unstructured":"Gebhardt BM, Varnell ED, Kaufman HE (2005) Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 21:114\u2013120","journal-title":"J Ocul Pharmacol Ther"},{"key":"1539_CR100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/02713680490504588","volume":"29","author":"BM Gebhardt","year":"2004","unstructured":"Gebhardt BM, Varnell ED, Kaufman HE (2004) Acetylsalicylic acid reduces viral shedding induced by thermal stress. Curr Eye Res 29:119\u2013125","journal-title":"Curr Eye Res"},{"key":"1539_CR101","first-page":"4351460","volume":"2018","author":"X Qi","year":"2018","unstructured":"Qi X, Wang M, Li X et al (2018) Characteristics of new onset herpes simplex keratitis after keratoplasty. J Ophthalmol 2018:4351460","journal-title":"J Ophthalmol"},{"key":"1539_CR102","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1128\/jvi.70.8.5051-5060.1996","volume":"70","author":"WP Halford","year":"1996","unstructured":"Halford WP, Gebhardt BM, Carr DJ (1996) Mechanisms of herpes simplex virus type 1 reactivation. J Virol 70:5051\u20135060","journal-title":"J Virol"},{"key":"1539_CR103","first-page":"1558","volume":"32","author":"SD Cook","year":"1991","unstructured":"Cook SD, Paveloff MJ, Doucet JJ et al (1991) Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci 32:1558\u20131561","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR104","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1096\/fasebj.6.8.1592204","volume":"6","author":"H Gronemeyer","year":"1992","unstructured":"Gronemeyer H (1992) Control of transcription activation by steroid hormone receptors. FASEB J 6:2524\u20132529","journal-title":"FASEB J"},{"key":"1539_CR105","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3181\/00379727-140-36592","volume":"140","author":"BE Sheffy","year":"1972","unstructured":"Sheffy BE, Davies DH (1972) Reactivation of a bovine herpesvirus after corticosteroid treatment. Proc Soc Exp Biol Med 140:974\u2013976","journal-title":"Proc Soc Exp Biol Med"},{"key":"1539_CR106","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/jvi.66.4.2484-2490.1992","volume":"66","author":"D Rock","year":"1992","unstructured":"Rock D, Lokensgard J, Lewis T, Kutish G (1992) Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J Virol 66:2484\u20132490","journal-title":"J Virol"},{"key":"1539_CR107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2567.2007.02611.x","volume":"122","author":"H-Y Lim","year":"2007","unstructured":"Lim H-Y, M\u00fcller N, Herold MJ et al (2007) Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 122:47\u201353","journal-title":"Immunology"},{"key":"1539_CR108","first-page":"1402","volume":"41","author":"H Cheng","year":"2000","unstructured":"Cheng H, Tumpey TM, Staats HF et al (2000) Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci 41:1402\u20131409","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-020-01539-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:48:21Z","timestamp":1631231301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-020-01539-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01539-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest to disclosure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}